AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,163,000 | +18.8% | 22,524 | -0.3% | 0.01% | 0.0% |
| Q4 2020 | $979,000 | +24.2% | 22,584 | +0.3% | 0.01% | +16.7% |
| Q3 2020 | $788,000 | -34.7% | 22,524 | -0.1% | 0.01% | -40.0% |
| Q2 2020 | $1,206,000 | +37.0% | 22,544 | -9.1% | 0.01% | +25.0% |
| Q1 2020 | $880,000 | +27.2% | 24,799 | +71.0% | 0.01% | +33.3% |
| Q4 2019 | $692,000 | +73.0% | 14,499 | +17.5% | 0.01% | +50.0% |
| Q3 2019 | $400,000 | -67.8% | 12,339 | -50.4% | 0.00% | -50.0% |
| Q2 2019 | $1,241,000 | -10.1% | 24,889 | +21.7% | 0.01% | -11.1% |
| Q1 2019 | $1,380,000 | +47.6% | 20,459 | +0.9% | 0.01% | +28.6% |
| Q4 2018 | $935,000 | -39.4% | 20,286 | +1.4% | 0.01% | -30.0% |
| Q3 2018 | $1,543,000 | +56.5% | 20,013 | +70.9% | 0.01% | 0.0% |
| Q2 2018 | $986,000 | +143.5% | 11,709 | +136.6% | 0.01% | -9.1% |
| Q1 2018 | $405,000 | – | 4,949 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |